NOVAN INC (NOVN) Stock Fundamental Analysis

NASDAQ:NOVN • US66988N2053

0.0941 USD
-0.03 (-24.84%)
At close: Jul 25, 2023
0.0894 USD
0 (-4.99%)
After Hours: 7/25/2023, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall NOVN gets a fundamental rating of 2 out of 10. We evaluated NOVN against 191 industry peers in the Pharmaceuticals industry. NOVN may be in some trouble as it scores bad on both profitability and health. NOVN is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year NOVN has reported negative net income.
  • NOVN had a negative operating cash flow in the past year.
NOVN Yearly Net Income VS EBIT VS OCF VS FCFNOVN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M -50M

1.2 Ratios

  • The profitability ratios for NOVN are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOVN Yearly ROA, ROE, ROICNOVN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 1K 2K

1.3 Margins

  • NOVN's Gross Margin of 66.06% is fine compared to the rest of the industry. NOVN outperforms 73.24% of its industry peers.
  • The Profit Margin and Operating Margin are not available for NOVN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NOVN Yearly Profit, Operating, Gross MarginsNOVN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -500 -1K -1.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • NOVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NOVN has more shares outstanding
  • The debt/assets ratio for NOVN is higher compared to a year ago.
NOVN Yearly Shares OutstandingNOVN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
NOVN Yearly Total Debt VS Total AssetsNOVN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -6.93, we must say that NOVN is in the distress zone and has some risk of bankruptcy.
  • NOVN has a worse Altman-Z score (-6.93) than 69.95% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.93
ROIC/WACCN/A
WACC8.45%
NOVN Yearly LT Debt VS Equity VS FCFNOVN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M -40M

2.3 Liquidity

  • A Current Ratio of 0.74 indicates that NOVN may have some problems paying its short term obligations.
  • With a Current ratio value of 0.74, NOVN is not doing good in the industry: 91.08% of the companies in the same industry are doing better.
  • NOVN has a Quick Ratio of 0.74. This is a bad value and indicates that NOVN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.72, NOVN is not doing good in the industry: 86.85% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.72
NOVN Yearly Current Assets VS Current LiabilitesNOVN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 21.76% over the past year.
  • Looking at the last year, NOVN shows a very strong growth in Revenue. The Revenue has grown by 512.74%.
  • The Revenue has been growing by 61.73% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)21.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.94%
Revenue 1Y (TTM)512.74%
Revenue growth 3Y69.07%
Revenue growth 5Y61.73%
Sales Q2Q%64.21%

3.2 Future

  • NOVN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.25% yearly.
  • NOVN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 62.45% yearly.
EPS Next Y78.75%
EPS Next 2Y44.82%
EPS Next 3Y29.1%
EPS Next 5Y23.25%
Revenue Next Year19.34%
Revenue Next 2Y95.98%
Revenue Next 3Y75.61%
Revenue Next 5Y62.45%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NOVN Yearly Revenue VS EstimatesNOVN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
NOVN Yearly EPS VS EstimatesNOVN Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80 -100

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NOVN. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 0.58, which indicates a rather cheap valuation of NOVN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of NOVN indicates a rather cheap valuation: NOVN is cheaper than 100.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.16, NOVN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.58
NOVN Price Earnings VS Forward Price EarningsNOVN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOVN Per share dataNOVN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NOVN's earnings are expected to grow with 29.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.82%
EPS Next 3Y29.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NOVN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NOVAN INC

NASDAQ:NOVN (7/25/2023, 8:00:02 PM)

After market: 0.0894 0 (-4.99%)

0.0941

-0.03 (-24.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-15
Earnings (Next)08-09
Inst Owners0.1%
Inst Owner Change-98.64%
Ins Owners20.94%
Ins Owner Change0%
Market Cap2.64M
Revenue(TTM)24.92M
Net Income(TTM)-32.05M
Analysts82.86
Price Target15.81 (16701.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.14%
Min EPS beat(2)-65.44%
Max EPS beat(2)71.72%
EPS beat(4)2
Avg EPS beat(4)5.66%
Min EPS beat(4)-65.44%
Max EPS beat(4)71.72%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)9.01%
Min Revenue beat(2)-51.38%
Max Revenue beat(2)69.4%
Revenue beat(4)1
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-51.38%
Max Revenue beat(4)69.4%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)43.52%
PT rev (3m)24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.87%
EPS NY rev (1m)49.28%
EPS NY rev (3m)49.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.42%
Revenue NY rev (1m)-12.59%
Revenue NY rev (3m)-12.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.58
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.51
EYN/A
EPS(NY)0.16
Fwd EY173.43%
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS0.89
BVpS-0.1
TBVpS-1.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.06%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.74%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.72
Altman-Z -6.93
F-Score3
WACC8.45%
ROIC/WACCN/A
Cap/Depr(3y)946.74%
Cap/Depr(5y)585.56%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.94%
EPS Next Y78.75%
EPS Next 2Y44.82%
EPS Next 3Y29.1%
EPS Next 5Y23.25%
Revenue 1Y (TTM)512.74%
Revenue growth 3Y69.07%
Revenue growth 5Y61.73%
Sales Q2Q%64.21%
Revenue Next Year19.34%
Revenue Next 2Y95.98%
Revenue Next 3Y75.61%
Revenue Next 5Y62.45%
EBIT growth 1Y-10.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11.42%
OCF growth 3YN/A
OCF growth 5YN/A

NOVAN INC / NOVN FAQ

Can you provide the ChartMill fundamental rating for NOVAN INC?

ChartMill assigns a fundamental rating of 2 / 10 to NOVN.


What is the valuation status for NOVN stock?

ChartMill assigns a valuation rating of 4 / 10 to NOVAN INC (NOVN). This can be considered as Fairly Valued.


How profitable is NOVAN INC (NOVN) stock?

NOVAN INC (NOVN) has a profitability rating of 1 / 10.


Can you provide the financial health for NOVN stock?

The financial health rating of NOVAN INC (NOVN) is 0 / 10.


What is the expected EPS growth for NOVAN INC (NOVN) stock?

The Earnings per Share (EPS) of NOVAN INC (NOVN) is expected to grow by 78.75% in the next year.